The World Health Organization says it is temporarily halting its clinical trials that use hydroxychloroquine to treat COVID -19 patients over published concerns that the drug may do more harm than good. The move comes after the medical journal The Lancet reported on Friday May 22 that patients getting hydroxychloroquine were dying at higher rates than other coronavirus patients. The WHO has 3,500 patients from 17 countries enrolled in what it calls the Solidarity Trial. This is an effort overseen by the WHO to find new treatments for COVID -19. READ MORE
Exploring all angles to events that shape the world